Table 2.
Crosslinked proteins | Detected crosslinked peptide | Potential mechanism of crosslinking | Reference |
---|---|---|---|
βA4 crystallin C5-βA4 crystallin C166 | βA4 2–7:acetyl-T LQC*TK βA4 159–174: GFQYVLEC* DHHSGDYK |
DHA-mediated | Wang et al., 2014 |
βA4 crystallin C5-βA3 crystallin S59 | βA4 2–7: acetyl-TLQC*TK βA3 46–64: MEFTSSCPNV SERS * FDNVR |
||
βB2 crystallin K76-βB2 crystallin S204 | βB2 69–81: GEQFVFEK* GEYPR βB2 199–205: GAFHPS*Da |
||
βB1 crystallin S77-γS crystallin C130 | βB1 74–86: AEFS*GECSNLADR βS 126–131: EIHSC*K |
||
AQP0 N246-AQP0 K228 | AQP0 239–263: GAKPDV SN*GQPEVTGEPVELDTQAL AQP0 227–233: LK*SISER |
Succinimide | Friedrich et al., 2018 |
AQP0 N259-Lys | AQP0 239–263: GAKPDV SNGQPEVTGEPVELN * TQAL Unknown (maybe αB): K |
||
βB1 crystallin K118-Spectrin D1207 | βB1 111–123: GEMFILEK*GEYPR Spectrin 1207–1210: D*LR |
||
βB2 crystallin K76-Spectrin D1207 | βB2 69–81: GEQFVFEK*GEYPR Spectrin 1207–1210: D*LR |
||
αA crystallin D151-αB crystallin K150 | αA 146–157: IQTGLD*ATHAER αB 150–157: K*QVSGPER |
||
AQP0 D246-AQP0 K228 | AQP0 227–233: LK*SISER AQP0 239–246: GAKPDVSD* |
succinic anhydride | unpublished |
AQP0 K238-AQP0 D246 | AQP0 234–243: LSVLK*GAKPD AQP0 239–246:GAKPDVSD* |
||
αA crystallin D101-αB crystallin K174 | αA:HD* αB: EEKPAVTAAPK*K |
||
αA crystallin D101-αB crystallin K150 | αA:HD* αB: K*QVSGPER |
||
AQP0 M1-AQP0 D243 | AQP0 1–5: *MWELR AQP0 239–243: GAKPD* |
succinic anhydride | Wang et al., 2019 |
AQP0 D243-AQP0 K228 | AQP0 227–233: LK*SISER AQP0 239–243: GAKPD* |
||
AQP0 D243-γS crystallin K14 | AQP0 239–243: GAKPD* γS 8–19: ITFYEDK*NFQGR |
||
αA crystallin D151-αB crystallin K150 | αA: IQTGLD* αB:K*QVSGPER |
||
αA crystallin K78-αA crystallin D58 | αA:FVIFLDVK*HPSPEDLTVK αA: TVLD* |
||
αB crystallin D129 - αB crystallin K90 | αB: IPADVD* αB: HFSPEELK*VK |
||
αB crystallin D129 - αB crystallin K82 | αB: IPADVD* αB: VK*VLGDVIEVHGK |
||
αB crystallin D129 - αB crystallin K121 | αB: IPADVD* αB: K*YR |
||
αA crystallin D151 - αB crystallin K82 | αA: IQTGLD* αB: VK*VLGDVIEVHGK |
||
αA crystallin D151 – γC or yD crystallin G2 | αA: IQTGLD* γC or γD: *GK |
||
Filensin K467-βA4 Q195 or βA3 Q214 | Filensin: SPKEPETPTELYTK#ER βA4 or βA3: IQ#Q |
transglutaminase | unpublished |
Filensin Q245-Phakinin K342 | Filensin: VELQAQ* TTTLEQAIK Phakinin: ALK*R |
||
Filensin K12-Phakinin Q361 | Filensin: K#EQYEHADEASR Phakinin: HWHDMELQ#NLGAVVGR | ||
αA crystallin K99 -αB crystallin K150 | αA: VQDDFVEIHGK#HNER αB: KQ#VSGPER |
||
βB1 crystallin Q236-Filensin K451 | βB1: Q*WHLEGSFPVLATEPPK Filensin: EK*VR |
||
Phakinin Q329-Phakinin C65 | Phakinin: VELHNTS CQV Q#SLQAETESLR Phakinin: #CIGGLGAR |
?? | |
γD crystallin E8-γDcrystallin K3 | γD: HYE*CSSDHPNLQPYLSR γD: G(carbamyl)K*ITLYEDR |
unknown | unpublished |
αB crystallin E99 -αB crystallin K121 | αB: VLGDVIE*VHGK αB: K*YR |
||
βB3 crystallin E177- γS K154 | βB3: GE*YR γS: QYLLDK*K |
bolded residues indicate an Asp residue resulting from deamidation of an Asn residue in the nascent protein sequence.